Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2012; 18(14): 1602-1609
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1602
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1602
Groups | 24 h | 48 h | ||
A value | Inhibitory rate (%) | A value | Inhibitory rate (%) | |
Control | 0.879 ± 0.048 | 0.00 ± 0.00 | 0.932 ± 0.036 | 0.00 ± 0.00 |
Toxicarioside A (μg/mL) | ||||
0.5 | 0.793 ± 0.062 | 9.79 ± 7.63 | 0.752 ± 0.073 | 19.13 ± 5.38 |
1.5 | 0.646 ± 0.041 | 27.83 ± 4.78a | 0.596 ± 0.113 | 36.19 ± 3.81a |
4.5 | 0.528 ± 0.078 | 40.18 ± 3.32a | 0.443 ± 0.056 | 49.32 ± 5.17b |
9.0 | 0.352 ± 0.092 | 61.84 ± 6.61b | 0.301 ± 0.049 | 66.94 ± 7.03b |
-
Citation: Guo JL, Zheng SJ, Li YN, Jie W, Hao XB, Li TF, Xia LP, Mei WL, Huang FY, Kong YQ, He QY, Yang K, Tan GH, Dai HF. Toxicarioside A inhibits SGC-7901 proliferation, migration and invasion
via NF-κB/bFGF signaling. World J Gastroenterol 2012; 18(14): 1602-1609 - URL: https://www.wjgnet.com/1007-9327/full/v18/i14/1602.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i14.1602